42 SPXIQ

ABBV AbbVie Inc.

Healthcare · Drug Manufacturers - General

$233.66 +6.4% upside
Mean Target
$248.69
Consensus
1.9 - Buy
Analysts
29
Rank
#366 / 499
Upside Rank
#316
Analyst Price Target Distribution
$184
Low
$250
Median
$249
Mean
$299
High
Current $234
Mean $249
Median $250
97 estimates
Consensus
1.9 - Buy
52-Wk Low
$164.39
52-Wk High
$244.81
50-Day Avg
$224.23
Recent Analyst Ratings
FirmRatingTargetPriorDate
RBC Capital Outperform $260 — 2026-02-25
Barclays Overweight $275 — 2026-02-20
Piper Sandler Overweight $299 $289 2026-02-18
UBS Neutral $230 $240 2026-02-05
Evercore ISI Group Outperform $228 $232 2026-02-05
Healthcare Peers
ABT A ALGN AMGN BAX BDX TECH BIIB BSX BMY CAH CNC COR CRL CI COO CVS DHR DVA DXCM EW ELV GEHC GILD